About this trial
This study aims to evaluate the efficacy of a probiotic complex (containing Bifidobacterium animalis subsp. lactis B94 and Lacticaseibacillus helveticus R0052) in maintaining gut microbiota homeostasis and supporting physiological and psychological stability among healthy Chinese adults during short-term travel to Europe.
Eligibility criteria
Qualifiers
Aged 18-65 years, regardless of gender;
Planning to undertake a short-term round-trip journey to Europe (within 7 days);
Able to understand and willing to comply with the study protocol, and to cooperate with study procedures;
Voluntarily sign the informed consent form before any study-related procedures are initiated.
Disqualifiers
Diseases that may affect the evaluation of trial results, such as immune dysfunction, severe renal/hepatic dysfunction, severe cardiovascular disease, malignant tumors, acute or chronic infections, etc.;
Use of probiotic preparations, antibiotics, hormones, immunosuppressants, biological agents, or JAK inhibitors within 4 weeks;
Subjects with diagnosed or uncontrolled parasitic infections;
Patients receiving long-term medication for chronic diseases;
Trial design
Treatments tested in this trial
- Placebo
- Probiotic
Treatment groups
Sponsors and collaborators
Min-Tze LIONG
Lead sponsor
Universiti Sains Malaysia
Sponsor institution
Tsinghua University
Collaborator